Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Jan 25, 2017
Insider Transaction Report
Form 4
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right To Purchase)
2017-01-23−25,000→ 75,504 totalExercise: $2.04Exp: 2023-10-11→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2017-01-23$2.04/sh+25,000$51,000→ 595,602 total
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 100,504 shares of Common Stock, became exercisable on June 1, 2014, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.